Lubner David Charles - Insider Non-Derivative Transactions at POINT Biopharma Global Inc. (PNT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 27, 2023, Lubner David Charles's relationship to POINT Biopharma Global Inc. (PNT) is Director, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other PNT insiders.
Data Source: SEC.
Lubner David Charles - Insider Non-Derivative Transactions of PNT Common Stock
Lubner David Charles - Insider Non-Derivative Transactions at PNT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 28, 2023 | Disposition -- (Common Stock) | 3600 | 0 | 0 |
| Dec 27, 2023 | U -- (Common Stock) | 35400 | 0 | 3600 |